Levodopa-induced ocular dyskinesias in Parkinson's disease.

about

Clinical spectrum of levodopa-induced complications.Motor Complications of Dopaminergic Medications in Parkinson's Disease.

P2860

Q34452721-A9C7D640-9EB9-458F-8F5A-54555FA2DF40 Q55279095-D6CB3BE7-D9FE-4CE7-AA35-CF6EE9DAF0C5

P2860

Levodopa-induced ocular dyskinesias in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q42164140

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@en

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@nl

type

Item

label

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@en

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@nl

prefLabel

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@en

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@nl

P1476

Levodopa-induced ocular dyskinesias in Parkinson's disease.

@en

P2093

Asier Lasa

http://www.w3.org/2001/XMLSchema#string

Begoña Indakoetxea

http://www.w3.org/2001/XMLSchema#string

Gurutz Linazasoro

http://www.w3.org/2001/XMLSchema#string

Javier Ruiz

http://www.w3.org/2001/XMLSchema#string

Nadege Van Blercom

http://www.w3.org/2001/XMLSchema#string

P2860

Ocular microtremor in patients with idiopathic Parkinson's disease

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

Ageing and Parkinson's disease: substantia nigra regional selectivity

Coexistence of tics and parkinsonism: evidence for non-dopaminergic mechanisms in tic pathogenesis.

Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis.

Tics in a patient with Parkinson's disease.

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.

P304

186-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.10017

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11526263

http://www.w3.org/2001/XMLSchema#string

P698

11835460

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

levodopa

dyskinesia

Levodopa-induced ocular dyskinesias in Parkinson's disease.

about

P2860

P2860

Levodopa-induced ocular dyskinesias in Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921